Lexaria Appoints Michael Shankman as Chief Financial Officer

Stock Information for Lexaria Bioscience Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lexaria Bioscience Corp.

Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
Lexaria Updates Current GLP-1 Market
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
Lexaria Releases Strategic Letter from the Outgoing CEO
Lexaria Welcomes Industry Veteran as New CEO
Lexaria Enters a Material Transfer Agreement for DehydraTECH Research
Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus Oral Capsules
Lexaria's Second GLP-1 Human Pilot Study Shows Zero Adverse Events in DehydraTECH-processed Rybelsus(R) Oral Capsules

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.